Literature DB >> 30755731

Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion.

Wenchu Wang1,2,3,4, Xin Yang1,2,3,4, Jinlu Dai2, Yi Lu5, Jian Zhang1,3,4,5, Evan T Keller6,7.   

Abstract

Bone is the most frequent site of prostate cancer (PCa) metastasis; however, little is known about the role of the most common cell in bone, the osteocyte (OCy), in cancer biology. In this study we explored the crosstalk between PCa cells and OCys to determine if it contributes to PCa progression. PCa cells induced OCys to promote PCa proliferation, migration and invasion. A chemokine screen revealed that PCa cell induced OCys to produce growth-derived factor 15 (GDF15). Knockdown of GDF15 in OCys demonstrated that PCa cells conferred the ability on OCys to promote PCa proliferation, migration and invasion through GDF15. Consistent with this finding was the observation that the GDF15 receptor, GFRAL, was expressed on multiple PCa cell lines. Transcription factor array screening of PCa cells exposed to OCys with or without knockdown of GDF15 revealed that GDF15 in OCys promoted early growth response 1 (EGR1) expression in the PCa cells. Knockdown of EGR1 expression in PCa cells revealed it was required for the OCy-derived GDF15-mediated induction of in vitro PCa cell proliferation, migration and invasion. Subcutaneous co-injection of PCa cells and OCys into mice revealed that OCys promoted tumor growth in vivo, which was diminished by knockdown of GDF15 in the OCys. Knockdown of GDF15 in the tibiae diminished growth of PCa cancer cells injected into the tibiae, which was accompanied by decreased tumor cell proliferation and EGR1 expression. These results shed light on a novel mechanism through which PCa cells educate OCys to promote progression of PCa bone metastasis. They also suggest that targeting of GDF15-based and EGR1-based signaling pathways should be further explored for their potential to diminish progression of PCa bone metastasis.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30755731      PMCID: PMC9097780          DOI: 10.1038/s41388-019-0736-3

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   8.756


  66 in total

1.  Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15.

Authors:  Jer-Yuan Hsu; Suzanne Crawley; Michael Chen; Dina A Ayupova; Darrin A Lindhout; Jared Higbee; Alan Kutach; William Joo; Zhengyu Gao; Diana Fu; Carmen To; Kalyani Mondal; Betty Li; Avantika Kekatpure; Marilyn Wang; Teresa Laird; Geoffrey Horner; Jackie Chan; Michele McEntee; Manuel Lopez; Damodharan Lakshminarasimhan; Andre White; Sheng-Ping Wang; Jun Yao; Junming Yie; Hugo Matern; Mark Solloway; Raj Haldankar; Thomas Parsons; Jie Tang; Wenyan D Shen; Yu Alice Chen; Hui Tian; Bernard B Allan
Journal:  Nature       Date:  2017-09-27       Impact factor: 49.962

Review 2.  A review of osteocyte function and the emerging importance of sclerostin.

Authors:  Jocelyn T Compton; Francis Y Lee
Journal:  J Bone Joint Surg Am       Date:  2014-10-01       Impact factor: 5.284

Review 3.  EGR-1, the reluctant suppression factor: EGR-1 is known to function in the regulation of growth, differentiation, and also has significant tumor suppressor activity and a mechanism involving the induction of TGF-beta1 is postulated to account for this suppressor activity.

Authors:  C Liu; A Calogero; G Ragona; E Adamson; D Mercola
Journal:  Crit Rev Oncog       Date:  1996

4.  Cloning and characterization of a novel member of the transforming growth factor-beta/bone morphogenetic protein family.

Authors:  V M Paralkar; A L Vail; W A Grasser; T A Brown; H Xu; S Vukicevic; H Z Ke; H Qi; T A Owen; D D Thompson
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

5.  Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo.

Authors:  Véronique Baron; Giorgia De Gregorio; Anja Krones-Herzig; Thierry Virolle; Antonella Calogero; Rafael Urcis; Dan Mercola
Journal:  Oncogene       Date:  2003-07-03       Impact factor: 9.867

6.  Targeted knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated invasion of prostate cancer cells through suppressing EGR-1/NF-kappaB synergy.

Authors:  Jiajia Ma; Zijia Ren; Yang Ma; Lu Xu; Ying Zhao; Chaogu Zheng; Yinghui Fang; Ting Xue; Baolin Sun; Weihua Xiao
Journal:  J Biol Chem       Date:  2009-10-16       Impact factor: 5.157

7.  Transcriptional regulation of human protease-activated receptor 1: a role for the early growth response-1 protein in prostate cancer.

Authors:  Zaidoun Salah; Myriam Maoz; Gallina Pizov; Rachel Bar-Shavit
Journal:  Cancer Res       Date:  2007-10-15       Impact factor: 12.701

Review 8.  Osteoblastic metastasis in advanced prostate cancer.

Authors:  M Koutsilieris
Journal:  Anticancer Res       Date:  1993 Mar-Apr       Impact factor: 2.480

Review 9.  Egr1 transcription factor: multiple roles in prostate tumor cell growth and survival.

Authors:  Eileen D Adamson; Dan Mercola
Journal:  Tumour Biol       Date:  2002 Mar-Apr

10.  Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1.

Authors:  Evin Ozen; Aysim Gozukizil; Esra Erdal; Aykut Uren; Donald P Bottaro; Nese Atabey
Journal:  PLoS One       Date:  2012-08-13       Impact factor: 3.240

View more
  28 in total

Review 1.  Growth differentiation factor 15 (GDF15) in cancer cell metastasis: from the cells to the patients.

Authors:  Anna Spanopoulou; Vasiliki Gkretsi
Journal:  Clin Exp Metastasis       Date:  2020-06-05       Impact factor: 5.150

Review 2.  Osteocytes and Cancer.

Authors:  Fabrizio Pin; Matt Prideaux; Lynda F Bonewald; Andrea Bonetto
Journal:  Curr Osteoporos Rep       Date:  2021-11-13       Impact factor: 5.096

Review 3.  Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia.

Authors:  Jawed Akhtar Siddiqui; Ramesh Pothuraju; Parvez Khan; Gunjan Sharma; Sakthivel Muniyan; Parthasarathy Seshacharyulu; Maneesh Jain; Mohd Wasim Nasser; Surinder Kumar Batra
Journal:  Cytokine Growth Factor Rev       Date:  2021-11-17       Impact factor: 7.638

4.  Phenotypic characterization of two novel cell line models of castration-resistant prostate cancer.

Authors:  Michael C Haffner; Akshay Bhamidipati; Harrison K Tsai; David M Esopi; Ajay M Vaghasia; Jin-Yih Low; Radhika A Patel; Gunes Guner; Minh-Tam Pham; Nicole Castagna; Jessica Hicks; Nicolas Wyhs; Ruedi Aebersold; Angelo M De Marzo; William G Nelson; Tiannan Guo; Srinivasan Yegnasubramanian
Journal:  Prostate       Date:  2021-08-16       Impact factor: 4.104

Review 5.  Understanding cachexia in the context of metastatic progression.

Authors:  Anup K Biswas; Swarnali Acharyya
Journal:  Nat Rev Cancer       Date:  2020-03-31       Impact factor: 60.716

Review 6.  Mechanobiology of Bone Metastatic Cancer.

Authors:  Blayne A Sarazin; Claire L Ihle; Philip Owens; Maureen E Lynch
Journal:  Curr Osteoporos Rep       Date:  2021-11-03       Impact factor: 5.096

Review 7.  Cancer-Mediated Muscle Cachexia: Etiology and Clinical Management.

Authors:  Thomas Siff; Parash Parajuli; Mohammed S Razzaque; Azeddine Atfi
Journal:  Trends Endocrinol Metab       Date:  2021-04-19       Impact factor: 10.586

Review 8.  Role of Osteocytes in Cancer Progression in the Bone and the Associated Skeletal Disease.

Authors:  Manish Adhikari; Jesús Delgado-Calle
Journal:  Curr Osteoporos Rep       Date:  2021-04-05       Impact factor: 5.163

9.  Identification of hub genes in prostate cancer using robust rank aggregation and weighted gene co-expression network analysis.

Authors:  Zhen-Yu Song; Fan Chao; Zhiyuan Zhuo; Zhe Ma; Wenzhi Li; Gang Chen
Journal:  Aging (Albany NY)       Date:  2019-07-15       Impact factor: 5.682

Review 10.  Genetic Landscape of Prostate Cancer Conspicuity on Multiparametric Magnetic Resonance Imaging: A Systematic Review and Bioinformatic Analysis.

Authors:  Joseph M Norris; Benjamin S Simpson; Marina A Parry; Clare Allen; Rhys Ball; Alex Freeman; Daniel Kelly; Hyung L Kim; Alex Kirkham; Sungyong You; Veeru Kasivisvanathan; Hayley C Whitaker; Mark Emberton
Journal:  Eur Urol Open Sci       Date:  2020-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.